Monsanto Corp 's G.D. Searle Co unit said report operating loss 1987 , mainly due expense research development .
Searle chairman Sheldon Gilgore said Searle 's operating loss 1987 le 87 mln dlr operating loss 1986 .
He said Searle 's first quarter sale 21.8 pct 179 mln dlrs 147 mln dlrs year ago quarter .
In 1986 Searle 's sale 665 mln dlrs .
Gilgore said company intends sale three billion dlrs mid-1990s .
He said company anticipates approval Japan , U.S. , Italy , Spain U.K. ulcer treatment drug Cytotech .
He also said paper yet published drug shown prevent flare-up ulcer longer period time Tagamet , made SmithKline Beckman Corp & lt ; SKB > .
Other drug Searle 's pipeline include tissue plasminogen activator ( TPA ) , made different process Genentech's & lt ; GENE > TPA , expected approved marketing year .
Reuter & # 3 ; 